
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1038 | 973 | 1124 | 1185 | 1685 | 2236 |
Fund Return | 3.79% | -2.72% | 12.38% | 5.83% | 11% | 8.38% |
Place in category | 39 | 39 | 103 | 234 | 262 | 96 |
% in Category | 15 | 12 | 33 | 64 | 73 | 40 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
American Century Ultra Inv | 19.02B | -3.05 | 11.78 | 15.50 | ||
American Century Growth Inv | 9.25B | -2.12 | 11.64 | 14.25 | ||
American Century Select Inv | 4.47B | -1.96 | 11.62 | 14.08 | ||
American Century Heritage Inv | 3.83B | 0.13 | 8.53 | 10.19 | ||
American Century Mid Cap Value R6 | 2.84B | 3.86 | 5.99 | 8.54 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Low-Priced Stock | 20.95B | 0.88 | 6.36 | 8.48 | ||
JHancock Disciplined Value Mid Cap | 13.29B | 2.15 | 7.34 | 9.04 | ||
Vanguard Mid-Cap Value Index Admira | 12.89B | 2.61 | 6.94 | 8.47 | ||
Victory Sycamore Established Value6 | 9.86B | 1.70 | 7.31 | 10.52 | ||
MFS Mid Cap Value R6 | 9B | 0.75 | 6.83 | 9.01 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Zimmer Biomet | US98956P1021 | 2.99 | 112.37 | -0.72% | |
Enterprise Products Partners LP | US2937921078 | 2.01 | 34.22 | +0.23% | |
Henry Schein | US8064071025 | 1.99 | 69.07 | +0.85% | |
Conagra Brands | US2058871029 | 1.93 | 26.60 | -0.26% | |
Edison | US2810201077 | 1.82 | 58.75 | -0.29% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Sell | Strong Sell |
Technical Indicators | Strong Buy | Sell | Strong Sell |
Summary | Buy | Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review